Article

Intravitreal Steroid Injections and Anti-Infectives Post-Test

Related Videos
Related Content
AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency and control
October 15th 2024

AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency and control

Week in Review - October 5, 2024
October 13th 2024

Week in Review - October 5, 2024

UNITY Biotechnology hosting in-person and virtual Ophthalmology Day
October 15th 2024

UNITY Biotechnology hosting in-person and virtual Ophthalmology Day

EyePod: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
October 11th 2024

Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD

FDA approves Bausch + Lomb’s enVista Envy range of IOLs
October 14th 2024

FDA approves Bausch + Lomb’s enVista Envy range of IOLs

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial
Published: October 12th 2024 | Updated: October 11th 2024

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial

© 2024 MJH Life Sciences

All rights reserved.